Differential responsiveness of proliferation and cytokeratin release to stripped serum and oestrogen in the human breast cancer cell line, MCF-7

T. Tedone, M. Correale, A. Paradiso, S. J. Reshkin

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

In vitro research into hormone sensitivity and the relation to proliferation of cytokeratin release from cancer cells is scarce. Therefore, we examined the stimulation of proliferation and the release of cytokeratins in a breast cancer cell culture model. Cell growth was stimulated by 17β-oestradiol (10-11 M), stripped serum (10%) and by the two together. Cytokeratin release was stimulated only by stripped serum, oestradiol having no effect. After long incubation periods (>12 h), cytokeratin release also commenced in the control and oestradiol treatments. Release rate versus time analysis suggested that there are two different release processes. Cytokeratin release was first stimulated at a stripped serum concentration approximately 100 times lower than that which initiated proliferation. Pharmacological alteration of proliferation with cordyceptin resulted in growth changes without alterations in cytokeratin release. We conclude that cytokeratin release in these cells is unrelated to proliferation, independent of oestrogen action and probably in some way related to growth factor receptor function.

Original languageEnglish
Pages (from-to)849-856
Number of pages8
JournalEuropean Journal of Cancer
Volume32
Issue number5
DOIs
Publication statusPublished - May 1996

Fingerprint

Keratins
Estrogens
Breast Neoplasms
Cell Line
Serum
Estradiol
Keratin-12
Growth Factor Receptors
Growth
Cell Culture Techniques
Hormones
Pharmacology
Research
Neoplasms

Keywords

  • Breast cancer
  • CYFRA 21.1
  • Cytokeratins
  • Growth factors
  • Hormone
  • MCF-7
  • Oestrogen
  • Proliferation
  • TPA
  • TPS

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

Differential responsiveness of proliferation and cytokeratin release to stripped serum and oestrogen in the human breast cancer cell line, MCF-7. / Tedone, T.; Correale, M.; Paradiso, A.; Reshkin, S. J.

In: European Journal of Cancer, Vol. 32, No. 5, 05.1996, p. 849-856.

Research output: Contribution to journalArticle

@article{7c86a47691b84527a0c45832934f3095,
title = "Differential responsiveness of proliferation and cytokeratin release to stripped serum and oestrogen in the human breast cancer cell line, MCF-7",
abstract = "In vitro research into hormone sensitivity and the relation to proliferation of cytokeratin release from cancer cells is scarce. Therefore, we examined the stimulation of proliferation and the release of cytokeratins in a breast cancer cell culture model. Cell growth was stimulated by 17β-oestradiol (10-11 M), stripped serum (10{\%}) and by the two together. Cytokeratin release was stimulated only by stripped serum, oestradiol having no effect. After long incubation periods (>12 h), cytokeratin release also commenced in the control and oestradiol treatments. Release rate versus time analysis suggested that there are two different release processes. Cytokeratin release was first stimulated at a stripped serum concentration approximately 100 times lower than that which initiated proliferation. Pharmacological alteration of proliferation with cordyceptin resulted in growth changes without alterations in cytokeratin release. We conclude that cytokeratin release in these cells is unrelated to proliferation, independent of oestrogen action and probably in some way related to growth factor receptor function.",
keywords = "Breast cancer, CYFRA 21.1, Cytokeratins, Growth factors, Hormone, MCF-7, Oestrogen, Proliferation, TPA, TPS",
author = "T. Tedone and M. Correale and A. Paradiso and Reshkin, {S. J.}",
year = "1996",
month = "5",
doi = "10.1016/0959-8049(95)00660-5",
language = "English",
volume = "32",
pages = "849--856",
journal = "European Journal of Cancer",
issn = "0959-8049",
publisher = "Elsevier Ltd",
number = "5",

}

TY - JOUR

T1 - Differential responsiveness of proliferation and cytokeratin release to stripped serum and oestrogen in the human breast cancer cell line, MCF-7

AU - Tedone, T.

AU - Correale, M.

AU - Paradiso, A.

AU - Reshkin, S. J.

PY - 1996/5

Y1 - 1996/5

N2 - In vitro research into hormone sensitivity and the relation to proliferation of cytokeratin release from cancer cells is scarce. Therefore, we examined the stimulation of proliferation and the release of cytokeratins in a breast cancer cell culture model. Cell growth was stimulated by 17β-oestradiol (10-11 M), stripped serum (10%) and by the two together. Cytokeratin release was stimulated only by stripped serum, oestradiol having no effect. After long incubation periods (>12 h), cytokeratin release also commenced in the control and oestradiol treatments. Release rate versus time analysis suggested that there are two different release processes. Cytokeratin release was first stimulated at a stripped serum concentration approximately 100 times lower than that which initiated proliferation. Pharmacological alteration of proliferation with cordyceptin resulted in growth changes without alterations in cytokeratin release. We conclude that cytokeratin release in these cells is unrelated to proliferation, independent of oestrogen action and probably in some way related to growth factor receptor function.

AB - In vitro research into hormone sensitivity and the relation to proliferation of cytokeratin release from cancer cells is scarce. Therefore, we examined the stimulation of proliferation and the release of cytokeratins in a breast cancer cell culture model. Cell growth was stimulated by 17β-oestradiol (10-11 M), stripped serum (10%) and by the two together. Cytokeratin release was stimulated only by stripped serum, oestradiol having no effect. After long incubation periods (>12 h), cytokeratin release also commenced in the control and oestradiol treatments. Release rate versus time analysis suggested that there are two different release processes. Cytokeratin release was first stimulated at a stripped serum concentration approximately 100 times lower than that which initiated proliferation. Pharmacological alteration of proliferation with cordyceptin resulted in growth changes without alterations in cytokeratin release. We conclude that cytokeratin release in these cells is unrelated to proliferation, independent of oestrogen action and probably in some way related to growth factor receptor function.

KW - Breast cancer

KW - CYFRA 21.1

KW - Cytokeratins

KW - Growth factors

KW - Hormone

KW - MCF-7

KW - Oestrogen

KW - Proliferation

KW - TPA

KW - TPS

UR - http://www.scopus.com/inward/record.url?scp=0029940331&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029940331&partnerID=8YFLogxK

U2 - 10.1016/0959-8049(95)00660-5

DO - 10.1016/0959-8049(95)00660-5

M3 - Article

C2 - 9081365

AN - SCOPUS:0029940331

VL - 32

SP - 849

EP - 856

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

IS - 5

ER -